Peter P. Pfreundschuh
2020 - Korro Bio
In 2020, Peter P. Pfreundschuh earned a total compensation of $4.4M as Chief Financial Officer at Korro Bio.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Non-Equity Incentive Plan | $15,000 |
| Option Awards | $4,228,536 |
| Salary | $37,500 |
| Total | $4,351,036 |
Pfreundschuh received $4.2M in option awards, accounting for 97% of the total pay in 2020.
Pfreundschuh also received $70K in bonus, $15K in non-equity incentive plan and $37.5K in salary.
Rankings
In 2020, Peter P. Pfreundschuh's compensation ranked 2,595th out of 13,090 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,595 out of 13,090 | 80th |
Division Manufacturing | 998 out of 5,621 | 82nd |
Major group Chemicals And Allied Products | 368 out of 2,254 | 84th |
Industry group Drugs | 316 out of 1,954 | 84th |
Industry Pharmaceutical Preparations | 231 out of 1,459 | 84th |
Source: SEC filing on April 29, 2021.
Pfreundschuh's colleagues
We found two more compensation records of executives who worked with Peter P. Pfreundschuh at Korro Bio in 2020.
News
Korro Bio CEO David Lucchino's 2020 pay falls 29% to $5.2M
April 29, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett receives $26M in 2019
April 29, 2020
UroGen Pharma Ltd. CEO Ron Bentsur's 2018 pay jumps 202% to $6M
April 26, 2019